BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24189334)

  • 1. Metformin use and endometrial cancer survival.
    Nevadunsky NS; Van Arsdale A; Strickler HD; Moadel A; Kaur G; Frimer M; Conroy E; Goldberg GL; Einstein MH
    Gynecol Oncol; 2014 Jan; 132(1):236-40. PubMed ID: 24189334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin is associated with improved survival in endometrial cancer.
    Ko EM; Walter P; Jackson A; Clark L; Franasiak J; Bolac C; Havrilesky LJ; Secord AA; Moore DT; Gehrig PA; Bae-Jump V
    Gynecol Oncol; 2014 Feb; 132(2):438-42. PubMed ID: 24269517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes.
    Insin P; Prueksaritanond N
    Asian Pac J Cancer Prev; 2018 May; 19(5):1295-1302. PubMed ID: 29802690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
    Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
    Deng Y; Wang J; Li W; Xiong W; Wang X
    J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
    Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts.
    Al Hilli MM; Bakkum-Gamez JN; Mariani A; Cliby WA; Mc Gree ME; Weaver AL; Dowdy SC; Podratz KC
    Gynecol Oncol; 2016 Feb; 140(2):270-6. PubMed ID: 26607780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
    Arima R; Hautakoski A; Marttila M; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Hinkula M; Puistola U; Läärä E
    Gynecol Oncol; 2017 Dec; 147(3):678-683. PubMed ID: 29054569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
    Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do endometrial cancer patients benefit from metformin intake?
    Lemańska A; Zaborowski M; Spaczyński M; Nowak-Markwitz E
    Ginekol Pol; 2015 Jun; 86(6):419-23. PubMed ID: 26255448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin intake is associated with better survival in ovarian cancer: a case-control study.
    Kumar S; Meuter A; Thapa P; Langstraat C; Giri S; Chien J; Rattan R; Cliby W; Shridhar V
    Cancer; 2013 Feb; 119(3):555-62. PubMed ID: 23208739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of metformin in patients with endometrial cancer: a retrospective study.
    Seebacher V; Bergmeister B; Grimm C; Koelbl H; Reinthaller A; Polterauer S
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():291-6. PubMed ID: 27423029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
    Montes de Oca MK; Albright BB; Secord AA; Havrilesky LJ; Moss HA
    Int J Gynecol Cancer; 2021 Dec; 31(12):1549-1556. PubMed ID: 34725205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer.
    Nagle CM; Crosbie EJ; Brand A; Obermair A; Oehler MK; Quinn M; Leung Y; Spurdle AB; Webb PM;
    Gynecol Oncol; 2018 Jul; 150(1):99-105. PubMed ID: 29706522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.
    AlHilli MM; Mariani A; Bakkum-Gamez JN; Dowdy SC; Weaver AL; Peethambaram PP; Keeney GL; Cliby WA; Podratz KC
    Gynecol Oncol; 2014 Jun; 133(3):485-93. PubMed ID: 24690476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer.
    Mayer MJ; Klotz LH; Venkateswaran V
    J Urol; 2017 Apr; 197(4):1068-1075. PubMed ID: 27984108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy.
    Ezewuiro O; Grushko TA; Kocherginsky M; Habis M; Hurteau JA; Mills KA; Hunn J; Olopade OI; Fleming GF; Romero IL
    PLoS One; 2016; 11(1):e0147145. PubMed ID: 26788855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
    Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
    Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and ovarian cancer: more complex than just increasing risk.
    Shah MM; Erickson BK; Matin T; McGwin G; Martin JY; Daily LB; Pasko D; Haygood CW; Fauci JM; Leath CA
    Gynecol Oncol; 2014 Nov; 135(2):273-7. PubMed ID: 25220626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
    Taussky D; Preisser F; Karakiewicz PI; Tilki D; Lambert C; Bahary JP; Delouya G; Wistaff R; Laskine M; Nguyen PV; Durand M; Saad F
    Can J Urol; 2018 Oct; 25(5):9509-9515. PubMed ID: 30281009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.